SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-15-162834
Filing Date
2015-04-30
Accepted
2015-04-30 17:27:36
Documents
6
Effectiveness Date
2015-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A d895817ddefa14a.htm DEFA14A 50434
2 GRAPHIC g895817dsp_063.jpg GRAPHIC 10617
3 GRAPHIC g895817dsp_064a.jpg GRAPHIC 13425
4 GRAPHIC g895817dsp_064b.jpg GRAPHIC 10458
5 GRAPHIC g895817dsp_065.jpg GRAPHIC 13841
6 GRAPHIC g895817dsp_066.jpg GRAPHIC 13833
  Complete submission text file 0001193125-15-162834.txt   137864
Mailing Address 480 ARSENAL ST. BUILDING 1, SUITE 120 WATERTOWN MA 02472
Business Address 480 ARSENAL ST. BUILDING 1, SUITE 120 WATERTOWN MA 02472 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36281 | Film No.: 15820551
SIC: 2834 Pharmaceutical Preparations